The global aspiration biopsy needle in terms of revenue is to be worth nearly $900 million in 2022 and is poised to reach $ 1300million by year 2027.Factors such us the rising prevalence of cancer, initiatives undertaken by government and global health organizations and the increasing preference for minimally procedures are the major factors driving the growth of the aspiration and biopsy needle market .